{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:10Z","timestamp":1759104190275,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jneuroim.2007.11.005","type":"journal-article","created":{"date-parts":[[2008,1,20]],"date-time":"2008-01-20T07:30:53Z","timestamp":1200814253000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhibitory IgG receptor Fc\u03b3RIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis"],"prefix":"10.1016","volume":"194","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Bin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Windy","family":"Allman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamsher S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premkumar","family":"Christadoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2007.11.005_bib1","doi-asserted-by":"crossref","first-page":"10285","DOI":"10.1073\/pnas.0504578102","article-title":"Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells","volume":"102","author":"Aruna","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bst0310281","article-title":"Fc gamma RIIB activation leads to inhibition of signalling by independently ligated receptors","volume":"31","author":"Brauweiler","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(76)92644-1","article-title":"Immune complexes in myasthenia gravis","volume":"2","author":"Casali","year":"1976","journal-title":"Lancet."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib4","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.4049\/jimmunol.136.7.2437","article-title":"Immunotherapy for myasthenia gravis: a murine model","volume":"136","author":"Christadoss","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2249.2005.02847.x","article-title":"Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors","volume":"141","author":"Clynes","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib6","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1471-4906(01)02014-2","article-title":"Inflammation in autoimmunity: receptors for IgG revisited","volume":"22","author":"Dijstelbloem","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.167.2.919","article-title":"A dominant role for Fc gamma receptors in antibody-dependent corneal inflammation","volume":"167","author":"Hall","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib10","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.4049\/jimmunol.170.8.4318","article-title":"Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis","volume":"170","author":"Kagari","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib11","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.4049\/jimmunol.169.10.5851","article-title":"Development of inflammation in proteoglycan-induced arthritis is dependent on Fc gamma R regulation of the cytokine\/chemokine environment","volume":"169","author":"Kaplan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib12","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.175.12.7898","article-title":"Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia","volume":"175","author":"Liu","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib13","first-page":"180","article-title":"Significance of circulating immune complexes in myasthenia gravis","volume":"111","author":"Mathai","year":"2000","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2006.07.004","article-title":"CD4+ T and B cells cooperate in the immunoregulation of experimental autoimmune myasthenia gravis","volume":"179","author":"Milani","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0002-9440(10)63472-4","article-title":"Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis","volume":"163","author":"Muhlfeld","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.10721","article-title":"Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis","volume":"48","author":"Nabbe","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1084\/jem.191.5.899","article-title":"Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease","volume":"191","author":"Nakamura","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-8411(03)00034-9","article-title":"Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcgammaRIIB-deficient mice","volume":"20","author":"Nakamura","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0165-5728(00)00385-4","article-title":"Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR","volume":"111","author":"Poussin","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jneuroim.2004.08.002","article-title":"The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo","volume":"158","author":"Romi","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ard.62.1.37","article-title":"Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE","volume":"62","author":"Ronnelid","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clim.2004.04.005","article-title":"Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy","volume":"112","author":"Sun","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib24","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0002-9440(10)64302-7","article-title":"Both Fcgamma receptor I and Fcgamma receptor III mediate disease in accelerated nephrotoxic nephritis","volume":"162","author":"Tarzi","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2249.2004.02569.x","article-title":"Immune complex-stimulated production of interleukin-12 in peripheral blood mononuclear cells is regulated by the complement system","volume":"137","author":"Tejde","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.39.10.1359","article-title":"Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis","volume":"39","author":"Tsujihata","year":"1989","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib27","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.4049\/jimmunol.171.7.3847","article-title":"Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis","volume":"171","author":"Tuzun","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib28","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.4049\/jimmunol.172.9.5743","article-title":"Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS\/J mice","volume":"172","author":"Tuzun","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nmd.2005.11.005","article-title":"Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis","volume":"16","author":"Tuzun","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2006.01.015","article-title":"Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis","volume":"174","author":"Tuzun","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2003.08.043","article-title":"Association of the Fc gamma receptor IIA-R\/R131 genotype with myasthenia gravis in Dutch patients","volume":"144","author":"van der Pol","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib32","first-page":"159","article-title":"Myasthenia gravis","volume":"88","author":"Vincent","year":"2000","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/eji.200323772","article-title":"Vaccination with myelin oligodendrocyte glycoprotein adsorbed to alum effectively protects DBA\/1 mice from experimental autoimmune encephalomyelitis","volume":"33","author":"Wallberg","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.005_bib34","first-page":"1","article-title":"Experimental autoimmune myasthenia gravis in the mouse","volume":"vol. 3:8.1","author":"Wu","year":"1997"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807004262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807004262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:12:38Z","timestamp":1759047158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572807004262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":34,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0165572807004262"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.11.005","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory IgG receptor Fc\u03b3RIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}